AMSBIO has added mouse Leukemia Inhibitory Factor (mLIF) to its extensive range of stem cell research products. Functionally tested with mouse ES cells, the affordably-priced AMSBIO recombinant mLIF combines both high quality and high activity. Mouse Leukemia Inhibitory Factor is a lymphoid factor involved in a number of biological processes including neural and hematopoietic cell [...]

MENLO PARK, Calif. and IPSWICH, Mass.-- SwitchGear Genomics, Inc., a leading provider of products and services for studying regulatory elements in the human genome, announced that they have partnered with New England Biolabs, Inc. (NEB) to create a new dual reporter assay system that leverages the unique advantages of SwitchGear's LightSwitch™ Luciferase Assay System and [...]

Madison, WI - BellBrook Labs developed the EPIGEN Methyltransferase Assayearlier this year to enable screening for inhibitors of methyltransferases (MTs), a family of chromatin modifying enzymes that has recently become the focus of intense drug discovery efforts. Although other MT assay methods were available, none of them had the right combination of HTS compatibility and [...]

MALVERN, Pa.-- Reaction Biology Corporation ("RBC"), a leading contract research organization providing drug discovery services in epigenetics, today announced the rollout of a new product line, recombinant proteins for epigenetic research. RBC's initial offerings will emphasize the histone methyltransferases (HMTs), including exclusive targets for which there has been no previous commercial source. The enzymes offered [...]

Gaithersburg, Maryland and SEOUL, Korea - Seegene, the world's leading developer of multiplex molecular diagnostics (M-MoDx), today announced the commercialization of its second real-time assay based upon its new TOCE™ technology. The Anyplex™ II RV16 Detection Assay will provide clinicians with a powerful new tool to help prevent the spread of respiratory infections. The Anyplex [...]

BOSTON--The Pistoia Alliance, a precompetitive alliance of life science companies, technology vendors, publishers, and academic groups, has launched the Pistoia Alliance Sequence Squeeze competition to find the best algorithm for compressing next-generation sequencing (NGS) data. The winning entrant will receive a prize of US$15,000, which will be awarded by a prestigious judging panel that includes [...]

MILFORD, Mass. and SINGAPORE, -- Waters Corporation today welcomed Dr. Ganesh Anand's laboratory at the National University of Singapore into its Centers of Innovation Program, making it the first such Center in Asia. With this designation, Waters honors Assistant Professor Ganesh Anand and his colleagues at the Department of Biological Sciences at NUS for research [...]

Toronto, Canada —ACD/Labs is pleased to announce the release of ACD/Percepta, an advanced software platform for accurate in silico ADME/Tox and physicochemical property prediction, at AAPS 2011. The next generation of ACD/Labs software, Percepta gives users insight into the relationship between chemical structure and a multitude of ADME, toxicological, and physicochemical properties, judiciously focusing the [...]

Los Angeles, Calif. and Hopkinton, Mass. -- DxTerity Diagnostics, Inc. and Caliper Life Sciences, Inc. (NASDAQ: CALP) announced today that the companies have entered into a co-development and co-marketing strategic collaboration that will allow researchers to perform DxTerity’s NEATmultiplex diagnostic assays on Caliper’s LabChip Dx instrument platform minimizing sample processing time without compromising data quality. [...]

LEXINGTON, Mass. & ALISO VIEJO, Calif.--RainDance Technologies, Inc., the Digital Biology™ Company, and Ambry Genetics, today announced the launch of a comprehensive targeted sequencing panel to screen genes involved with drug absorption, distribution, metabolism, and excretion (ADME) research. The ADMESeq™ Research Screening Panel enables researchers to simultaneously interrogate 242 known pharmacogenetic genes using next-generation sequencing [...]